Literature DB >> 23954192

Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.

Meehyein Kim1, So-Yeon Kim, Hye Won Lee, Jin Soo Shin, Pilho Kim, Young-Sik Jung, Hyeong-Seop Jeong, Jae-Kyung Hyun, Chong-Kyo Lee.   

Abstract

(-)-Epigallocatechin-3-gallate (EGCG), one of the major flavonoid components of green tea, is known to have a broad antiviral activity against several enveloped viruses, including the influenza virus. However, its mode of action and the mechanism that allows it to target influenza virus molecules have not been fully elucidated. Thus, this study investigated the molecular mechanism by which EGCG suppresses influenza virus infections. EGCG was found to block an early step in the influenza viral life cycle, but it did not affect viral adsorption to target cells or viral RNA replication. However, EGCG inhibited hemifusion events between virus particles and the cellular membrane by reducing the viral membrane integrity, thereby resulting in the loss of the cell penetration capacity of the influenza virus. EGCG also marginally suppressed the viral and nonviral neuraminidase (NA) activity in an enzyme-based assay system. In conclusion, it is suggested that the anti-influenza viral efficacy of EGCG is attributable to damage to the physical properties of the viral envelope and partial inhibition of the NA surface glycoprotein. These results may facilitate future investigations of the antiviral activity of EGCG against other enveloped viruses as well as influenza virus.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (−)-Epigallocatechin-3-gallate; Antiviral activity; Influenza virus; Membrane damage; Viral entry

Mesh:

Substances:

Year:  2013        PMID: 23954192     DOI: 10.1016/j.antiviral.2013.08.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  41 in total

1.  Green tea cultivar 'Benifuuki' potentiates split vaccine-induced immunoglobulin A production.

Authors:  Yeong-Seon Won; Motofumi Kumazoe; Kanako Takamatsu; Yuki Shinoda; Saki Sonoda; Kenji Okada; Takehisa Okamoto; Hirofumi Tachibana
Journal:  J Nat Med       Date:  2016-08-03       Impact factor: 2.343

Review 2.  Induction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoids.

Authors:  Sapna Patel; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2015-07-17       Impact factor: 4.388

3.  A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.

Authors:  Che C Colpitts; Luis M Schang
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

4.  Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha.

Authors:  Jun Xu; Weizhen Gu; Chaoyan Li; Xiao Li; Guozhen Xing; Yan Li; Yanhui Song; Wenming Zheng
Journal:  J Nat Med       Date:  2016-03-11       Impact factor: 2.343

5.  Nitraria schoberi L. hairy root culture as a source of compounds with antiviral activity against influenza virus subtypes А(H5N1) and А(H3N2).

Authors:  Tatiana Zheleznichenko; Evgenii Banaev; Sergey Asbaganov; Maria Voronkova; Tatiana Kukushkina; Ekaterina Filippova; Natalia Mazurkova; Larisa Shishkina; Tatyana Novikova
Journal:  3 Biotech       Date:  2018-05-15       Impact factor: 2.406

6.  Epigallocatechin-3-Gallate (EGCG) Inhibits SARS-CoV-2 Infection in Primate Epithelial Cells: (A Short Communication).

Authors:  Brett L Hurst; Douglas Dickinson; Stephen Hsu
Journal:  Microbiol Infect Dis       Date:  2021

7.  Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate.

Authors:  Jin Soo Shin; Keun Bon Ku; Yejin Jang; Yi-Seul Yoon; Daeho Shin; Oh Seung Kwon; Yun Young Go; Seong Soon Kim; Myoung Ae Bae; Meehyein Kim
Journal:  J Microbiol       Date:  2017-12-07       Impact factor: 3.422

8.  Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.

Authors:  Yejin Jang; Jin Soo Shin; Yi-Seul Yoon; Yun Young Go; Hye Won Lee; Oh Seung Kwon; Sehee Park; Man-Seong Park; Meehyein Kim
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

9.  Protein disulfide isomerases as potential therapeutic targets for influenza A and B viruses.

Authors:  Yunjeong Kim; Kyeong-Ok Chang
Journal:  Virus Res       Date:  2018-01-31       Impact factor: 3.303

Review 10.  Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.

Authors:  Mohammad Amin Khazeei Tabari; Amin Iranpanah; Roodabeh Bahramsoltani; Roja Rahimi
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.